Kirsti Aas
Associate Professor
-
Division of Surgery
![Image of Kirsti Aas](https://www.med.uio.no/klinmed/english/people/aca/kirsa/kirsa.jpg)
Norwegian version of this page
Username
Visiting address
Sykehusveien 25
1474 Nordbyhagen
Postal address
Akershus universitetssykehus
1478 Lørenskog
Other affiliations
Centres directly under the University Board
(Student)
Publications
-
Fosså, Sophie Dorothea; Storås, Anne Marie Holck; Aas, Kirsti; Johannessen, Tom Børge; Gjelsvik, Ylva Maria & Myklebust, Tor Åge (2024). Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer. European Urology Open Science. ISSN 2666-1691. 63, p. 62–70. doi: 10.1016/j.euros.2024.03.005.
-
Löffeler, Sven; Bertilsson, Helena Maria; Müller, Christoph Rainer; Aas, Kirsti; Haugnes, Hege Sagstuen & Aksnessæther, Bjørg Yksnøy [Show all 22 contributors for this article] (2024). Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU International. ISSN 1464-4096. doi: 10.1111/bju.16314. Full text in Research Archive Show summary
-
Nilsson, Mona Otrebski; Aas, Kirsti; Myklebust, Tor Åge; Gjelsvik, Ylva Maria; Haug, Erik Skaaheim & Fosså, Sophie Dorothea [Show all 7 contributors for this article] (2023). Do all prostate cancer patients want, and experience shared decision making prior to curative treatment? Scandinavian Journal of Urology. ISSN 2168-1805. 58, p. 133–140. doi: 10.2340/sju.v58.14730. Full text in Research Archive
-
Bjerner, Lars; Bratt, Ola; Aas, Kirsti; Albertsen, Peter C.; Fosså, Sophie D. & Kvåle, Rune [Show all 16 contributors for this article] (2023). Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium. European Urology. ISSN 0302-2838. p. 1–7. doi: 10.1016/j.eururo.2023.04.028.
-
Haug, Erik Skaaheim; Myklebust, Tor Åge; Jones, Charles Patrick W.; Reisæter, Lars Anders Rokne; Aas, Kirsti & Berg, Arne Stenrud [Show all 12 contributors for this article] (2023). Impact of prebiopsy MRI on prostate cancer staging: Results from the Norwegian Prostate Cancer Registry. BJUI Compass. ISSN 2688-4526. 4(3), p. 331–338. doi: 10.1002/bco2.214. Full text in Research Archive
-
Sacco, Matteo; Gandaglia, Giorgio; Aas, Kirsti; Ceci, Francesco; Chiu, Peter K. & Fankhauser, Christian D. [Show all 28 contributors for this article] (2022). The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management. Clinical Genitourinary Cancer. ISSN 1558-7673. 21(3). doi: 10.1016/j.clgc.2022.11.012.
-
Aas, Kirsti; Berge, Viktor; Myklebust, Tor Åge & Fosså, Sophie Dorothea (2021). Comparative survival outcomes of high-risk prostate cancer ttreated with radical prostatectomy or definitive radiotherapy regimens. European Urology Open Science. ISSN 2666-1691. 26, p. 55–63. doi: 10.1016/j.euros.2021.01.011. Full text in Research Archive Show summary
-
Fosså, Sophie Dorothea; Aas, Kirsti; Muller, Christoph Rainer; Jerm, Marianne Brenn; Tandstad, Torgrim & Lilleby, Wolfgang [Show all 10 contributors for this article] (2020). Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival. Radiotherapy and Oncology. ISSN 0167-8140. 155, p. 33–41. doi: 10.1016/j.radonc.2020.10.022. Full text in Research Archive Show summary
-
Aas, Kirsti; Fosså, Sophie Dorothea; Myklebust, Tor Åge; Møller, Bjørn; Kvåle, Rune & Vlatkovic, Ljiljana [Show all 7 contributors for this article] (2020). Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study. Cancer Medicine. ISSN 2045-7634. 9(18), p. 6646–6657. doi: 10.1002/cam4.3297. Full text in Research Archive
-
Fosså, Sophie Dorothea; Beyer, Bud; Dahl, Alv A; Aas, Kirsti; Eri, Lars Magne & Kvan, Espen [Show all 10 contributors for this article] (2019). Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique. Scandinavian Journal of Urology. ISSN 2168-1805. p. 1–7. doi: 10.1080/21681805.2019.1693625. Full text in Research Archive
-
Kvåle, Rune; Myklebust, Tor Åge; Fosså, Sophie Dorothea; Aas, Kirsti; Ekanger, Christian & Helle, Svein Inge [Show all 8 contributors for this article] (2019). Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer‐specific mortality. A population‐based study of 13 198 patients. The Prostate. ISSN 0270-4137. 79(16), p. 1852–1860. doi: 10.1002/pros.23911. Full text in Research Archive Show summary
-
Aas, Kirsti; Fosså, Sophie Dorothea; Kvåle, Rune; Møller, Bjørn; Myklebust, Tor Åge & Vlatkovic, Ljiljana [Show all 8 contributors for this article] (2018). Is time from diagnosis to radical prostatectomy associated with oncological outcomes? . World Journal of Urology. ISSN 0724-4983. 37(8), p. 1571–1580. doi: 10.1007/s00345-018-2570-6.
-
Aas, Kirsti; Axcrona, Karol; Kvåle, Rune; Møller, Bjørn; Myklebust, Tor Åge & Axcrona, Ulrika [Show all 8 contributors for this article] (2017). Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway. Urology. ISSN 0090-4295. 110, p. 140–147. doi: 10.1016/j.urology.2017.07.048.
-
Aas, Kirsti; Fosså, Sophie Dorothea; Kvåle, Rune; Møller, Bjørn; Myklebust, Tor Åge & Vlatkovic, Ljiljana [Show all 8 contributors for this article] (2018). Increasing Time from Diagnosis to Radical Prostatectomy (RP-interval) is Not Associated with Adverse Oncological Outcomes: Implications for cancer patient pathways (CPPs). European Urology. Supplement. ISSN 1569-9056. 17(14), p. e2825–e2827. doi: 10.1016/S1569-9056(18)33709-6.
Published
Mar. 2, 2023 3:02 PM
- Last modified
Apr. 28, 2023 1:28 PM